---
figid: PMC3918721__TSWJ2014-521754.001
figlink: /pmc/articles/PMC3918721/figure/fig1/
number: Figure 1
caption: 'TGF-β signaling and MMPs interplay. Active TGF-β binds to its cell-surface
  type II receptor (TBRII), inducing the activation of TGF-β type I receptor (ALK5
  or TBRI) and forming a heterotetrameric complex. Then two sets of signaling pathways
  can be stimulated: the Smad pathway, where ALK5 phosphorylates Smad2,3 and promotes
  the release of Smads from the complex with SARA from the inner face of the plasma
  membrane (phosphorylated Smad2,3 interact with co-Smad4, forming a heteromeric complex
  to be translocated into the cell nucleus) and non-Smad pathways, where active TGF-β-receptor
  complex interacts with ubiquitin ligase tumor necrosis factor receptor-associated
  factor 6 (TRAF6) which in turn recruits TGF-β activated kinase 1 (TAK1) to activate
  p38, JNK, or NFκB pathway. On the other hand, TGF-β binding provokes the phosphorylation
  of ALK5 at tyrosine residues which enable the formation of Shc-Grb2/SoS complex
  to activate Ras-Raf1-MEK1,2-ERK1,2 signaling. Finally, receptor activated complexes
  can activate PI3K, provoking the activation of AKT and the small Rho GTPases. The
  activation of both Smad and non-Smad signaling pathways in turn initiate transcriptional
  or nontranscriptional activity to regulate MMPs expression, thus incrementing the
  protein levels in tumor microenvironment. When membrane bound MMPs or soluble MMPs
  are expressed, they may promote the activation of latent TGF-β by proteolytic cleavage
  within the N-terminal region of the latency-associated peptide (LAP) or the large
  latent complex (LLC).'
pmcid: PMC3918721
papertitle: 'Transforming Growth Factor-Beta and Matrix Metalloproteinases: Functional
  Interactions in Tumor Stroma-Infiltrating Myeloid Cells.'
reftext: Jelena Krstic, et al. ScientificWorldJournal. 2014;2014:521754.
pmc_ranked_result_index: '122936'
pathway_score: 0.8633472
filename: TSWJ2014-521754.001.jpg
figtitle: TGFB signaling and MMPs interplay
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3918721__TSWJ2014-521754.001.html
  '@type': Dataset
  description: 'TGF-β signaling and MMPs interplay. Active TGF-β binds to its cell-surface
    type II receptor (TBRII), inducing the activation of TGF-β type I receptor (ALK5
    or TBRI) and forming a heterotetrameric complex. Then two sets of signaling pathways
    can be stimulated: the Smad pathway, where ALK5 phosphorylates Smad2,3 and promotes
    the release of Smads from the complex with SARA from the inner face of the plasma
    membrane (phosphorylated Smad2,3 interact with co-Smad4, forming a heteromeric
    complex to be translocated into the cell nucleus) and non-Smad pathways, where
    active TGF-β-receptor complex interacts with ubiquitin ligase tumor necrosis factor
    receptor-associated factor 6 (TRAF6) which in turn recruits TGF-β activated kinase
    1 (TAK1) to activate p38, JNK, or NFκB pathway. On the other hand, TGF-β binding
    provokes the phosphorylation of ALK5 at tyrosine residues which enable the formation
    of Shc-Grb2/SoS complex to activate Ras-Raf1-MEK1,2-ERK1,2 signaling. Finally,
    receptor activated complexes can activate PI3K, provoking the activation of AKT
    and the small Rho GTPases. The activation of both Smad and non-Smad signaling
    pathways in turn initiate transcriptional or nontranscriptional activity to regulate
    MMPs expression, thus incrementing the protein levels in tumor microenvironment.
    When membrane bound MMPs or soluble MMPs are expressed, they may promote the activation
    of latent TGF-β by proteolytic cleavage within the N-terminal region of the latency-associated
    peptide (LAP) or the large latent complex (LLC).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD6
  - SMAD5
  - SMAD4
  - SMAD2
  - SMAD3
  - MAP2K1
  - PIK3R3
  - AKT1
  - PIK3CD
  - AKT3
  - KRAS
  - TGFBR1
  - LTB
  - MAP2K2
  - RHOD
  - SHE
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CG
  - PIK3R6
  - AKT2
  - BRAF
  - ARAF
  - HRAS
  - TGFBR2
  - NRAS
  - TGFB2
  - TGFB3
  - MAPK14
  - MAP2K3
  - SMAD7
  - SMAD9
  - PIK3CB
  - RAF1
  - TGFB1
  - SOS1
  - SMAD1
  - NFKB1
  - REL
  - MAPK12
  - RELB
  - SOS2
  - RELA
  - MAPK11
  - MAPK13
  - MAP2K6
  - NFKB2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: MEK1,2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ALKS/TBRI
  symbol: TBR-i
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: LTB
  symbol: LTB
  source: hgnc_symbol
  hgnc_symbol: LTB
  entrez: '4050'
- word: MEK1,2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: She
  symbol: SHE
  source: hgnc_symbol
  hgnc_symbol: SHE
  entrez: '126669'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: TBRII
  symbol: TBRII
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MEK3,6
  symbol: MEK3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MEK3,6
  symbol: MEK6
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
